10 January 2008 14:15
Can-Fite to collaborate with leading academic institutes on hepatitis C drug
BioPharma announced that cooperation agreements were signed with two worldwide leading research laboratories to promote the company s second drug pipeline, CF102. This cooperation will facilitate joint research to investigate the effect of CF102 on the hepatitis C virus (HCV).
1
(1 marks)